Use of a radioactively labelled molecule specifically binding to ED-B fibronectin in a method of Hodgkin lymphoma

Details for Australian Patent Application No. 2009243715 (hide)

International Classifications

Event Publications

11 November 2010 PCT application entered the National Phase

PCT publication WO2009/135627 Priority application(s): WO2009/135627

23 December 2010 Amendment Made

The nature of the amendment is: Amend invention title to read Use of a radioactively labelled molecule specifically binding to ED-B fibronectin in a method of treatment of Hodgkin lymphoma

21 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

Application withdrawn under section 141(1). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.